In conversation with Middle Class Hub, Dr Nisheeth Kumar talks about the significance of pharmacovigilance sector as an option for medics who don’t want to go into clinical practice, shares his perspective on clinical research, clinical trial, the COVID-19 pandemic, explains why medical education is out of bounds of the middle class, and suggests that doctors be at the forefront of policymaking when it comes to healthcare.
Take a listen!
